Introduction
DNA replication in mammalian cells is a complex process and highly ordered during the progression of the cell cycle. The replication process requires a series of components which are prepared at G1 phase. These components may be induced transcriptionally in expression, activated and/or repressed in function in a strictly time-dependent manner. Some of these assemble at G1 while others dissociate to proceed in other stages of the cell cycle. The initiation of DNA replication is a crucial step and is regulated by subtle mechanisms, although such mechanisms remain to be elucidated in mammalian cells.
Most of our understanding of the molecular mechanisms responsible for the initiation of DNA replication is based on genetic and biochemical studies of the yeast system. A set of molecules that control the initiation of DNA replication has been identi®ed. These include six proteins consisting a multisubunit complex known as the origin recognition complex (ORC) (Bell and Stillman, 1992; Diey and Cocker, 1992) , which binds to autonomously replicating origins of DNA. The binding between ORC and the replication origin is observed throughout the cell cycle (Aparicio et al., 1997) . Thus, regulation of initiation of DNA replication is thought to be determined by molecules that functionally or physically interact with ORC. Several molecules capable of interacting with ORC have been identi®ed; possible candidates are Cdc6, licensing factors Mcms, a Dbf4/Cdc7 kinase complex and Cdc45 (Dowell et al., 1994; Hardy, 1997; Liang et al., 1995; Zou et al., 1997) . Among these, Cdc6 has been shown to determine the rate of initiation through interaction with ORC (Liang et al., 1995) . In addition, Cdc6 is necessary for loading of Mcm proteins onto the DNA replication origin complex (Donovan et al., 1997; Tanaka et al., 1997) . cdc18, a Schizosaccharomyces pombe (S. pombe) homolog of CDC6, induces re-replication of DNA, when overexpressed (Muzi-Falconi and Kelly, 1995; Nishitani and Nurse, 1995) . These results indicate that CDC6/cdc18 is an important determinant of the initiation of DNA replication in yeasts.
Expression of CDC6 is cell cycle-regulated. In rapidly replicating cells, it is expressed at late mitosis and the expression is regulated by Mcm1 (McInerny et al., 1997) . In nutrition limited state of yeast cells, CDC6 is expressed at G1/S boundary via activation by MBF (Piatti et al., 1995) . cdc18 of S. pombe expressed at G1/S boundary is regulated by cdc10/sct1 (Kelly et al., 1993) . MBF and cdc10/sct1 are similar to the mammalian transcription factor E2F in that their targets are genes involved in DNA replication and activation of these transcription factors are regulated by G1 cyclins and cyclin-dependent kinases (Cdks). Thus, although there is little, if any, homology among E2F, MBF and cdc10/sct1, these transcription factors can be regarded as functional homologs.
Transcriptional activity of E2F is regulated by G1 cyclins/Cdks through phosphorylation of Rb family proteins. Growth stimulation activates G1 cyclins/Cdks activity, resulting in expression of a class of genes required for DNA replication such as DNA polymerase a, dihydrofolate reductase (DHFR) and proliferating cell nuclear antigen (La Thangue, 1994; Nevins, 1992) . Therefore, the basic control mechanism of G1/S transition is conserved between yeast and mammals. Overexpression of E2F1 through E2F4 of the E2F family has been shown to induce cellular DNA synthesis in serum-starved quiescent ®broblasts (De-Gregori et al., 1997; Johnson et al., 1993; Qin et al., 1994; Shan and Lee, 1994) . Thus, molecules critically required for the initiation of DNA replication are probably targets of transactivation by E2F. However, most of the genes identi®ed so far as E2F targets encode molecules associated with enzymatic machinery for DNA synthesis. It is less likely that these gene products determine the initiation of DNA replication in mammalian cells.
Identi®cation of molecules that critically regulate the initiation of DNA replication in mammalian cells is central to the study of the molecular mechanism linking cell cycle and DNA replication. In this context, it is noteworthy that the expression of CDC6 and DBF4, interacting with ORC, is cell cycleregulated in yeast (Chapman and Johnston, 1989; Piatti et al., 1995; Zwerschke et al., 1994) . Interestingly, the expression of a human ORC1 homolog (HsOrc1) is growth-regulated in an E2F-dependent manner (Ohtani et al., 1996) , unlike the expression of yeast ORC1 which is independent of the cell cycle. These molecules are potential candidates for determining the initiation of DNA replication. In this regard, the recent identi®cation of a human homolog of CDC6, p62 CDC6 (HsCdc6), prompted us to examine whether the expression of HsCdc6 is regulated by E2F, considering cell cycle-dependent expression at G1/S boundary and the presence of putative E2F consensus sites in the 5'¯anking sequence (Williams et al., 1997) .
We demonstrate here that serum stimulationregulated activity of HsCdc6 promoter is primarily controlled by E2F through binding to the E2F recognition sites of the HsCdc6 promoter. In addition, our results also suggest that HsCdc6 as well as HsOrc1, both of which are targets of E2F, are not sucient for the initiation of DNA replication.
Results

Regulation of expression of Cdc6 gene in cell proliferation
Expression of HsCdc6 mRNA is induced by serum stimulation in WI38 human ®broblasts, but not in growing HeLa cells (Williams et al., 1997) . In order to con®rm that the expression of mammalian Cdc6 mRNA is growth regulated, we examined the expression of Cdc6 mRNA after serum stimulation of quiescent REF52 cells. Quiescence of REF52 cells was induced by culturing for 48 h in a medium containing 0.1% fetal calf serum and stimulation of cells by addition of serum to re-enter the cell cycle. RNA was extracted from cells harvested at quiescence and various time intervals after the addition of serum. Poly(A) + RNA was puri®ed and assayed for the levels of Cdc6 mRNA by Northern blotting. Serum-starved quiescent REF52 cells showed very low but a signi®cant level of mRNA for Cdc6 compared with asynchronously growing cells (Figure 1) . In contrast, 4 h after serum stimulation, the level of Cdc6 mRNA was little, if any. A profound increase in the mRNA level was observed 8 h after stimulation, and the maximum level occurred at 12 h. Furthermore, a persistently high level of Cdc6 mRNA was present at least until 28 h after stimulation. DNA synthesis determined by [ 3 H]thymidine uptake started 16 h after serum stimulation (data not shown). Accumulation of Cdc6 mRNA seemed to parallel proceeding to G1/S boundary of the cell cycle progression upon the addition of serum, indicating the cell growth regulation of the expression of mammalian Cdc6 gene. These results are similar to observations previously reported in WI38 human ®broblasts (Williams et al., 1997) .
Isolation and function of HsCdc6 promoter
In order to elucidate the molecular basis for the cell growth-regulated expression of mammalian Cdc6 gene, the next series of experiments aimed at identifying the transcriptional regulatory sequence. Screening of a human genomic DNA library (6610 5 ) with a 50 mer oligonucleotide corresponding to the 5' end of HsCdc6 cDNA identi®ed two positive clones. A 9.1-kb XhoI fragment and 4.6-kb XhoI fragment were separately isolated from the two positive clones. Sequence analysis showed that the 9.1-kb fragment encompassed 5' untranslated sequence and 5'¯anking sequence of HsCdc6 and this fragment contained the 4.6-kb XhoI fragment. No typical TATA-related sequences were seen and there were two putative E2F recognition sites (nt 743 to 736 and nt 78 to 71) adjacent to the transcriptional start site ( Figure  2 ), as previously reported (Williams et al., 1997) . There was no Sp1-like binding site unlike many of the E2F site-containing promoters (Karlseder et al., 1996; Lin et al., 1996) . The 5' end of the cDNA reported is numbered as+1.
We introduced these upstream sequences of HsCdc6 cDNA in front of the luciferase (Luc) gene in a reporter plasmid to investigate whether the 5'¯anking region promotes the HsCdc6 gene in response to growth stimulation. Three HsCdc6-Luc reporter plasmids containing dierent lengths of the 5'¯anking sequences, pHsCdc6-Luc(79000), pHsCdc6-Luc(74500) and pHsCdc6-Luc(7570), were transfected into REF52 cells along with pCMV-b-gal as an internal control. After transfection, the serum level in the medium was reduced to 0.1% to render the cells quiescent for 48 h. Serum was then added to stimulate Figure 1 Cell growth-dependent expression of Cdc6 mRNA. REF52 cells were serum starved and re-stimulated with 20% FCS. Cells were harvested at indicated time intervals after addition of serum and poly(A) + RNA prepared from 660 mg of total RNA was separated by agarose gel electrophoresis and transferred to nylon membrane. The blot was probed separately with HsCdc6 and GAPDH cDNAs. Lane A shows the results with RNA from asynchronously cultured cells E2F-mediated expression of mammalian CDC6 gene K Ohtani et al re-entry into the cell cycle. The promoter activity was assayed in serum-starved and serum-stimulated REF52 cells. Extracts from cells harvested at indicated time intervals were assayed for luciferase activities. In cells at early G1, the activity of HsCdc6 promoter of each of three Luc reporter plasmids was as low as that in quiescent cells ( Figure 3 ). As the cell cycle progressed through late G1 and G1/S boundary, luciferase activities increased markedly, consistent with the pattern of endogenous Cdc6 mRNA expression ( Figure 1 ). These results indicate that activation of the HsCdc6 promoter is induced at this stage of the cell cycle progression. Luciferase activity gradually declined after 20 h of stimulation with serum. Essentially, the three constructs, pHsCdc6-Luc(79000), pHsCdc6-Luc(74500) and pHsCdc6-Luc(7570), showed similar kinetics of activation of the HsCdc6 promoter in response to serum stimulation, albeit, with a minor dierence; pHsCdc6-Luc (7570) responded more markedly than pHsCdc6-Luc(79000) and pHsCdc6-Luc(74500), indicating that the essential regulatory region in response to serum stimulation is between 7570 and+98.
E2F-dependent regulation of HsCdc6 promoter
Based on the results showing the presence of two putative E2F recognition sequences within the HsCdc6 promoter, we then examined whether the E2F recognition sequences are primary regulatory elements responsive to growth stimulation. To test this possibility, the response of the isolated HsCdc6 promoter region to E2F was examined in a transient co-transfection assay. For this purpose, pHsCdc6-Luc(7570) was transfected into REF52 cells together with a plasmid expressing E2F1, E2F2 or E2F3. Following transfection, the cells were cultured in a medium containing 0.1% FCS for 48 h, and assayed for luciferase activity. Exogenous co-expression of E2F1 and E2F2 caused ®ve-and eight-fold increases in HsCdc6 promoter activity, respectively, and stimulation to a lesser extent was observed by E2F3 coexpression ( Figure 4A ). These results indicate that E2F plays a critical role in the regulation of HsCdc6 promoter activity.
To con®rm the important role of E2F recognition sequences in the expression of HsCdc6 gene, the promoter activity of a 670-bp fragment (7570 to+98) mutated in both putative E2F recognition sequences was compared with the wild type using the luciferase reporter assay. The wild type [pHsCdc6-Luc(7570)] and mutant promoter-linked luciferase reporter [pHsCdc6-Luc(7E2F)] constructs were introduced into REF52 cells along with the E2F1 expression vector. Quiescence of transfected cells was induced by culturing in medium with 0.1% FCS for 48 h, and luciferase activity in cell extracts was determined. As expected, under serum starvation, E2F1 expression induced 4.8-fold activation of the wild type promoter, however the mutant promoter exhibited a dierent response to E2F. The profoundly high activity of the mutant promoter was seen without E2F1. The level of mutant promoter activity was only slightly elevated by co-expression of E2F1, but the dierence between with (79000), pHsCdc6-Luc(74500) or pHsCdc6-Luc(7570). A CMV-b-galactosidase vector (2 mg) was simultaneously introduced as an internal control. Transfected cells were brought to quiescence and then stimulated with serum. Cell extracts were prepared from cells harvested at indicated time intervals. Luciferase and b-galactosidase activities were measured and activity of the former was normalized to that of b-galactosidase E2F-mediated expression of mammalian CDC6 gene K Ohtani et al and without E2F was not signi®cant ( Figure 4B ). Thus, we speculated that with regard to the regulation of expression of the HsCdc6 gene, E2F acts as a negative regulator in quiescent G0/G1 cells.
Binding of E2F to HsCdc6 promoter E2F sites
To gain insight into the molecular mechanism of regulation by the HsCdc6 promoter E2F, we investigated the ability of E2F recognition sequences in the promoter to bind E2F by gel mobility shift assay. The HsCdc6 E2F recognition sequence oligonucleotides 1 and 2 were able to generate complexes with partially puri®ed HeLa cell extract. Complex formation was competed away with the same oligonucleotides, but not with mutant forms of HsCdc6 promoter E2F oligonucleotides ( Figure 5A ).
Furthermore, complex formation between HeLa cell extract and typical E2F binding site of the DHFR promoter was inhibited by the wild type oligonucleotides of E2F recognition sequences 1 and 2 of the HsCdc6 promoter, but not by mutant forms of oligonucleotides ( Figure 5B ). These results indicate that the E2F recognition sequences in the HsCdc6 promoter are authentic E2F binding sites.
E2F-dependent activation of HsCdc6 promoter through cell cycle
Based on our results of growth-dependent control of Cdc6 gene expression, as shown by the Northern blot assay (Figure 1) , we investigated the role of E2F sites in HsCdc6 gene promoter in serum-stimulated growth progression. The wild type and mutant promoterluciferase reporter constructs were transfected into REF52 cells. Quiescence of transfected cells was induced by culturing in 0.1% FCS for 48 h followed by stimulation with serum. Cell extracts were prepared at various time intervals after serum stimulation and assayed for luciferase activities. The basal activity of the wild type HsCdc6 promoter markedly increased at G1/S boundary ( Figure 6 ) consistent with the results shown in Figure 3 . In contrast, the mutant promoter exhibited completely dierent kinetics relative to those of the wild type promoter, abolishing cell growthdependent control of promoter activity ( Figure 6 ). The activity of the mutant promoter in quiescence and early G1 stage was profoundly elevated. This was consistent with the results of co-transfection experiments shown in Figure 4 . These results demonstrate that the activity of the HsCdc6 promoter is regulated by E2F which primarily suppresses its expression in G0/G1 as has been reported for other E2F responsive genes such as B-myb, E2F1 and HsOrc1 (Johnson et al., 1994; Lam and Watson, 1993; Ohtani et al., 1996) .
Induction of endogenous Cdc6 gene expression by E2F1
Based on our analysis, it seemed likely that E2F is central in regulating the expression of HsCdc6 gene. The next series of experiments were performed to con®rm these results by examining the expression of endogenous Cdc6 gene in response to E2F in quiescent state. REF52 cells were rendered quiescent by serum starvation then infected with a recombinant adenovirus which expresses E2F1. Cells were harvested at 21 h after infection and RNA was extracted for Northern blot analysis (Figure 7) . The level of Cdc6 mRNA 
Eects of overexpression of HsCdc6 and HsOrc1 on cellular DNA synthesis
Overexpression of E2F1 has been shown to initiate cellular DNA synthesis in serum starved REF52 cells (Johnson et al., 1993) . HsCdc6 is an E2F-regulated gene and, furthermore, CDC6 determines the frequency of ®ring of DNA replication origins in yeast. Thus, it is possible that enforced expression of HsCdc6 induces the initiation of DNA replication in mammalian cells as is the case for overexpression of cdc18 in S. pombe. This notion was examined by cellular DNA synthesis in serum starved REF52 cells overexpressing HsCdc6. REF52 cells were transfected with the HsCdc6 expression vector along with a b-galactosidase expression vector and BrdU incorporation was measured in serum starved conditions. As shown in Figure 8 , expression of E2F1 induced BrdU incorporation in 40% of cells positive for b-galactosidase expression. This value, similar to the results of Johnson et al. (1993) , was signi®cantly higher than that of cells transfected with a control vector. In contrast, transfection with the HsCdc6 expression vector failed to induce signi®cant changes in BrdU incorporation relative to the background, even with as much as 10 times the plasmid DNA, in which the HsCdc6 gene was driven by the same CMV promoter as E2F1 expression vector. These results indicate that the HsCdc6 expression alone is not sucient for induction of DNA replication in REF52 cells.
In view of the fact that the expression of HsOrc1 is regulated by E2F in a growth stimulation manner similar to HsCdc6 (Ohtani et al., 1996) , we also examined whether transfection with HsOrc1 expression vector could induce cellular DNA synthesis in a similar fashion. Introduction of HsOrc1 expression plasmid DNA at 0.5 mg and 5.0 mg did not alter the number of BrdU positive cells relative to the background, demonstrating that HsOrc1 alone is not sucient for initiation of DNA replication. Collectively, neither Cdc6 nor Orc1 is the sole E2F target gene for the induction of cellular DNA synthesis in REF52 cells. Gel mobility shift assays were performed with partially puri®ed HeLa cell extract and end-labeled double stranded oligonucleotides containing the putative E2F recognition site 1 (lanes 1 ± 4) and putative E2F recognition site 2 (lanes 5 ± 8) from the HsCdc6 promoter. Competition assays were performed by adding 100-molar excess of the unlabeled oligonucleotides of wild and mutant forms to gel shift reaction mixtures. (B) Competitive activity in E2F binding. Gel mobility shift assays were performed with partially puri®ed HeLa cell extract. An end-labeled DNA fragment which contains two overlapping E2F recognition sites of the DHFR promoter was used as a probe. Competition experiments were performed by adding 100-fold molar excess of unlabeled oligonucleotides to gel shift reaction mixtures. Competitor oligonucleotides included the putative E2F recognition site 1 from the HsCdc6 promoter (lane 11) and its mutant form (lane 12), putative E2F recognition site 2 (lane 13) and its mutant form (lane 14). Lanes 9 and 10 contain no cell extract, and cell extract with no competitors, respectively E2F-mediated expression of mammalian CDC6 gene K Ohtani et al
Discussion
The major ®nding of the present study is that the growth-regulated expression of mammalian Cdc6 is mediated by E2F.
The 570-bp region upstream of HsCdc6 encompasses the transcriptional regulatory region of the HsCdc6 gene, and the kinetics of promoter activity in response to serum stimulation, as determined by the reporter assay with the isolated fragment, were similar to those of the endogenous promoter assayed by Northern blot hybridization (Figure 3 vs Figure 1 ). The fragment contains two E2F binding sites which are close to each other and adjacent to the RNA start site. It is of interest to note that most E2F binding sites in genes that are primarily regulated in expression by E2F are located near RNA start sites in a multiple copy form in transcriptional regulatory regions.
Disruption of E2F binding sites in the HsCdc6 promoter abolished the ability to regulate transcription of the gene in response to growth stimulation, clearly demonstrating that E2F is responsible for regulation of expression of the HsCdc6 gene. This conclusion was supported by the ®nding that, in quiescent cells, the enforced expression of E2F was able to relieve repression of the HsCdc6 gene promoter. E2F on the HsCdc6 promoter seems to be suppressive in quiescent cells, because a mutant HsCdc6 promoter disrupted with the E2F binding sites exhibited promoter activity without serum stimulation as high as that of the wild type promoter in cells at G1/S boundary. This is consistent with previous observations of E2F-dependent regulation with genes for B-myb, E2F1 and HsOrc1 (Johnson et al., 1994; Lam and Watson, 1993; Ohtani et al., 1996) . Previous studies showed that quiescent REF52 cells have E2F in a complex form preferentially associated with p130 in contrast to cycling REF52 cells having E2F complexed with pRb and p107 (Smith et al., 1996) , suggesting that the E2F/ p130 complex functions as a machinery that silences the HsCdc6 promoter. Overexpression of E2F could The mechanism of initiation of DNA replication in mammalian cells has been investigated by identifying counterparts homologous to yeast components involved in the regulation of initiation of DNA replication. Successful identi®cation of human homologs of ORC1 and 2, CDC6 and 7, and MCM2-7 (Fujita et al., 1996; Gavin et al., 1995; Hu et al., 1993; Musahl et al., 1995; Sato et al., 1997; Thommes et al., 1992; Todorov et al., 1995; Tsuruga et al., 1997b; Williams et al., 1997) suggests that the main stream of the regulatory mechanism involved in initiation of DNA replication is conserved between humans and yeasts. Indeed, the mechanisms that regulate the expression of CDC6 gene are similar in humans and yeasts. As shown in the present results as well as those from other laboratories (Williams et al., 1997) , the HsCdc6 gene is transcribed at G1/S boundary in an E2F-regulatory manner. S. cerevisiae under nutritionlimited conditions similarly expressed CDC6 mRNA at G1/S boundary in an MBF-dependent manner. MBF is thought to be functionally equivalent to E2F in mammalian cells. However certain dierences in regulation of the expression of homologous genes exist between both species. Even in S. cerevisiae, the CDC6 gene in rapidly replicating cells is expressed at late mitosis under regulation by Mcm1 but not by MBF (McInerny et al., 1997) . Another example is the ORC gene. Expression of ORC mRNA and protein in S. cerevisiae is independent of the cell cycle; in contrast, HsOrc1 mRNA expression in human fibroblasts is greatly induced upon growth stimulation (Ohtani et al., 1996) . Thus, it is suggested that HsOrc1 is involved in regulation of the initiation of DNA replication in response to growth stimulation in mammalian cells. Expression of Mcm genes is also dierentially regulated in yeasts and humans. In yeasts, the expression of Mcms is independent of the cell cycle. However, in human, a set of the MCM gene family has been shown to be induced upon growth stimulation (Tsuruga et al., 1997a) . Preliminary results from our laboratory indicate that the expression of human homologs of MCM5 and MCM6 genes is regulated by E2F (unpublished data).
The growth-dependent expression of a group of genes regulatory to DNA replication is reasonable, considering that most cells are quiescent in adults and a small population of cells are cycling or induced to proliferate in certain conditions such as injury and immune stimulation. In this regard, more genes involved in the regulation of initiation of DNA replication might have become growth-responsive in mammals. Moreover, this regulation is achieved by the action of E2F transcription factor. These observations underscore the importance of E2F not only in cell cycle regulation but also in cell growth in general. Thus, it is important to know whether the expression of these genes is cell cycle-regulated in cycling cells, and, if so, expression of which of these genes is important for regulation of the initiation of DNA replication. At present, it is unclear which molecule among the machinery interacting with ORC is critical for the initiation of DNA replication in mammalian cells. The mechanism of assembly of these gene products induced by E2F may be critical for such initiation process, and the assembly may even depend on a critical amount of each molecule. Alternatively, the fully functional ORC complex including Orcl and Cdc6 may be activated by other yet unknown mechanism(s) which may be also regulated by molecules aected by E2F in their expression. In this regard, it is noteworthy that expression of cyclin E, which is necessary for entry into S phase, is regulated by E2F (Geng et al., 1996; Ohtani et al., 1995) . Cyclin E-dependent kinase activity could be required for activation of the functional ORC complex by phosphorylation of some components in the complex.
In S. cerevisiae, the CDC6 gene product determines the rate of ®ring of origins (Liang et al., 1995) . On the other hand, in S. pombe, overexpression of CDC6 homolog, cdc18, has been shown to induce rereplication of DNA (Nishitani and Nurse, 1995) . Thus, it seems that CDC6/cdc18 is the main regulator of initiation of DNA replication in yeasts. In our experimental system, overexpression of either HsOrc1 or HsCdc6 alone did not induce DNA synthesis unlike overexpression of E2F1 in REF52 cells. Thus, it is clear that Orc1 or Cdc6 alone is not the sole E2F target gene in inducing DNA synthesis in REF52 cells. A series of experiments in yeast suggested that both Orc1 and Cdc6 may be critical targets of E2F in inducing DNA replication in REF52 cells. Considered together, the expressions of Orc1 and Cdc6 may be necessary but not sucient for induction of initiation of DNA synthesis in REF52 cells, suggesting that other molecules may be necessary for the initiation of DNA replication. If this is true, E2F overexpression must induce the expression of those molecules in addition to Orc1 and Cdc6. Among such molecules, members of the MCM family and a mammalian CDC7 homolog are potential candidates. Furthermore, as yet an unidenti®ed mammalian homolog of yeast DBF4 may also be involved in initiation of DNA replication, considering the presence of mammalian CDC7 homolog and the cell cycle-dependent expression of DBF4 by MBF in yeast. Thus, a combination of those molecules may bypass the requirement of normal regulation for the initiation of DNA replication.
It is noteworthy that overexpression of E2F induces cellular DNA synthesis in ®broblasts with kinetics similar to those of serum stimulation Kowalik et al., 1995) . Considering that E2F activity is tightly involved in G1 cyclin /Cdk activation (Geng et al., 1996; Ohtani et al., 1995) , it is possible that overexpression of E2F induces a set of genes that are activated by serum stimulation and evokes a cascade of reactions as in serum stimulation. Induction of Orc1 and Cdc6 could be one set of such genes in this scenario.
Materials and methods
Cell culture
A rat embryonic ®broblast cell line REF52 was maintained in Dulbecco modi®ed Eagle medium (DMEM) containing 10% FCS. For experiments of promoter activity assay and expression of endogenous Cdc6 mRNA, REF52 cells were serum starved in DMEM containing 0.1% FCS for 48 h and stimulated by the addition of 20% FCS for indicated time intervals.
Isolation of HsCdc6 promoter sequences
A human placenta genomic DNA library (6610 5 clones, Clontech) was screened with a 50 mer oligonucleotide corresponding to the 5' end of the published HsCdc6 cDNA sequence (Williams et al., 1997) . Labeling of the probe with DIG-UTP, hybridization and detection of positive signals were carried out using DIG Oligonucleotide 3'-End Labeling Kit and DIG Luminescent Detection Kit (Boehringer Mannheim, Germany) according to the protocol recommended by the manufacturer with the following modi®cations. Hybridization was performed with 45% formamide at 408C and washing was performed in a solution with 0.56SSC and 0.1% SDS at 558C. Two positive clones were ®nally isolated. Sequencing was performed by the primer walking method using a DNA sequencing kit and 310 genetic analyzer (Perkin Elmer) according to the protocol recommended by the manufacturer.
Construction of plasmids
The 9.1-kbp XhoI fragment (nt 79000 to+134) and 4.6-kbp XhoI fragment (nt 74500 to+134) were isolated from the two clones using XhoI sites in the 5' untranslated region of HsCdc6 cDNA and in the multiple cloning sites of the phage vector, and subcloned into the XhoI site of a Luc reporter plasmid pGL2basic (Promega) to make pHsCdc6-Luc(79000) and pHsCdc6-Luc(74500), respectively. A 670-bp BamHI fragment (nt 7570 to+98), common for both clones, was subcloned into the BglII site of pGL2basic to make pHsCdc6-Luc(7570). Mutation was introduced into the putative E2F recognition sites of the HsCdc6 promoter region in the pHsCdc6-Luc(7570) construct by site-directed mutagenesis which changed TTTGGCGG (nt 743 to 736) to TTTGATGG and TTTGGCGC (nt 78 to 71) to TTTGATGC, generating pHsCdc6-Luc(-E2F). The E2F1, E2F2, and E2F3 expression plasmids, as well as b-galactosidase expression vector, pCMV-b-gal, have been described previously (Johnson et al., 1994) . To prepare HsCdc6 and HsOrc1 expression vectors, HsCdc6 cDNA (nt 61 to 1917) and HsOrc1 cDNA (nt 84 to 2963) ampli®ed by PCR using Pfu DNA polymerase (Stratagene) from 293 cell cDNA were ®rst cloned into the EcoRV site of pBluescript SK 7 generating pBSK-HsCdc6 and pBSK-HsOrc1, respectively. Subsequently, the HsCdc6 cDNA and HsOrc1 cDNA were cut out and subcloned into an expression vector pcDNA3 (Invitrogen) to make pCMV-HsCdc6 and pCMV-HsOrc1, respectively. Sequencing of both cDNAs found a nucleotide substitution (A to G) at nt 154 in the 5' untranslated region of the HsCdc6 cDNA and C to A change at nt 1965 of the HsOrc1 cDNA which changed an amino acid at 582 from His to Gln which is not conserved between species.
Transfection assay
Transfection of REF52 cells and luciferase assay were performed as described previously (Johnson et al., 1993) . Expression plasmids and reporter plasmids were introduced into REF52 cells by the calcium-phosphate method. bGalactosidase expression vector pCMV-b-gal was cotransfected as an internal control to monitor transfection eciency. Luciferase activities were normalized to bgalactosidase activities. All assays were performed at least three times in duplicates and representative data are presented.
Gel mobility shift assay Double-stranded oligonucleotides containing each of the two putative E2F recognition sites (nt 743 to 736 and 78 to 71) in the 5'¯anking region of HsCdc6 and mutants of these sequences were used for the assay. Sequences are: wild type-1: 5'-CCGGGCTTTGGC-GGGAGGTGGG-3'; mutant-1: 5'-CCGGGCTTTGATG-GGAGGTGGG-3'; wild type-2: 5'-TTCGGATTTGGCG-CGAGCGCGG-3'; mutant-2: 5'-TTCGGATTTGATGC-GAGCGCGG-3'.
These double-stranded oligonucleotides were also used as competitors at 100-fold molar excess. A typical E2F site from the DHFR promoter (Ikeda et al., 1996) was also used as a probe. Gel mobility shift assay was performed as described previously (Yee et al., 1989) . In brief, radio-labeled probes were incubated with partially puri®ed HeLa nuclear extract (Ikeda and Nevins, 1993) , in the presence or absence of unlabeled competitor oligonucleotides for 20 min at room temperature, followed by eletrophoresis in a 5% polyacrylamide gel in TBE (50 mM Tris-borate/1 mM EGTA) containing 5% glycerol.
Northern (RNA) blot assay
Total RNA extraction and poly (A) + RNA puri®cation were carried out using Isogen (Nippon Gene) and PolyA Tract (Promega), respectively, according to the protocol recommended by the manufacturer. Gel electrophoresis, transfer to nylon membrane, and hybridization were performed as described previously (Johnson et al., 1994) . The HsCdc6 probe was a 1856-bp SmaI-SalI fragment cut out of pBSK-HsCdc6. The GAPDH cDNA was used as a control probe. Radioactivity of the signals was measured with an image analyzer BAS 1500 (Fuji Film).
Infection with recombinant adenoviruses
The recombinant adenovirus for expression of E2F1, Ad-E2F1, and control virus, Ad-Con (previously Ad-CMV), were described previously . Infection of REF52 cells with Ad-E2F1 or Ad-Con was performed as described previously . Brie¯y, quiescent REF52 cells cultured in DMEM containing 0.1% FCS for 48 h were infected with Ad-E2F1 or AdCon at multiples of 300 plaque forming units per cell in 2 ml per 150 mm plate for 1 h at 378C. Cells were further cultured in DMEM containing 0.1% FCS for 21 h and harvested for RNA isolation.
DNA synthesis induction assay
The assay was performed using the method described previously by Johnson et al. (1993) with minor modifications. Brie¯y, REF52 cells were transfected by the calcium phosphate coprecipitation method with 5 mg RSV-b-gal and 500 ng or 5 mg of either E2F1, HsCdc6 or HsOrc1 expression vector. pcDNA1 was used as a control vector while pBluescript SK 7 was used as a carrier DNA to prepare a total DNA amount of 20 mg. Cells were exposed to DNA precipitate for 16 h, washed and then cultured in DMEM containing 0.1% FCS for 48 h. BrdU was added to a ®nal concentration of 50 mM and the cells were further incubated for 24 h. The cells were ®xed with 4% paraformaldehyde in PBS for 10 min at room temperature and then dehydrated with methanol/acetone (1 : 1) for 5 min at room temperature. b-Galactosidase was stained with a rabbit polyclonal antibody (1 : 500 in 1% BSA/PBS) (Cappel) and FITC-conjugated goat anti-rabbit IgG (1 : 500 in 1% BSA/PBS) (Cappel). Cells were ®xed again with 4% paraformaldehyde and then treated with 2 N HCl for 30 min at room temperature. They were subsequently stained with an anti-BrdU monoclonal antibody (1 : 50 in 1% BSA/PBS) (Boehringer-Mannheim) and rhodamineconjugated goat anti-mouse IgG (1 : 500 in 1% BSA/PBS) (Cappel). The number of BrdU positive cells in bgalactosidase positive cells was counted under a fluorescence microscope equipped with appropriate ®lters. Experiments were repeated four times and in each experiment, more than 200 b-galactosidase positive cells were counted in each sample. Results were presented as a mean of four experiments.
Nucleotide sequence accession number
The nucleotide sequence data reported in this paper have been given a sequence of DDBJ, EMBL and GenBank accession number of AB010492.
